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therefore these measurements were not included in the
blueprint.4
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Assessment of acid–base disorders
To the Editor: Adrogue´ et al.1 give an overview of the three
distinct approaches that are currently used in assessing
acid–base disorders. In contrast to their assumption that the
chloride level is normal in high anion gap acidosis (Table 2),
there is often a low plasma chloride level because the plasma
chloride decreases relative to sodium in these cases.2 They
also assume that there is no signiﬁcant effect of the plasma
albumin on acid–base status in the physiological approach.
This is not the case, as we have to adjust the anion gap for the
plasma albumin.1 Indeed, after this adjustment there is no
effect of albumin on the metabolic acid–base component. In
the clinical case example 2, the authors give the impression
that the physiological approach acknowledges a metabolic
alkalosis and the physicochemical approach only diagnoses a
hypoalbuminemic alkalosis. This is probably not true. A
decrease in plasma albumin level by 1 g/dl usually results in
an increase in bicarbonate level by 2.8mmol/l.3 Accordingly,
with a serum albumin level of 1.5mmol/l, the expected serum
bicarbonate level in this case will be 24þ 3 2.8
(8.4)¼ 32.4mmol/l. The patient’s serum bicarbonate is higher
(35mmol/l), probably because of an additional metabolic
alkalosis caused by the low potassium level of 3.2mmol/l. In
this context, the two approaches are therefore less different
than the authors suggest. The fact that the secondary DPaCO2
is not deﬁned in metabolic acidosis and alkalosis according to
the physicochemical approach1 is probably the most im-
portant limitation of this method, as additional respiratory
disturbances may be missed.
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The Authors Reply: We respectfully disagree with the
comments made by Dr Berend.1 The study he quoted to
counter our ‘assumption that the chloride level is normal in
high anion gap acidosis’ failed to detect absolute hypochlor-
emia in patients with this condition.2 Thus, normochloremic
acidosis is an appropriate and standard term for high anion
gap acidosis. This term allows differentiation of high anion
gap acidosis from the normal anion gap acidosis that features
hyperchloremia.
The need to adjust the plasma anion gap for the anionic
charge of plasma albumin, a simple computation performed
routinely by clinicians, is unrelated to the proposed effect of
albumin itself on acid–base status. As stated in our paper,3
there is no evidence that the body, and in particular, the liver,
regulates albumin to maintain acid–base balance. A role of
albumin itself in the regulation of acid–base status is accepted
by neither the physiological nor the base-excess approach.
Dr Berend claims that our assessment of example 2 is pro-
bably incorrect because we did not consider that a decrease in
plasma albumin by 1 g/dl results in an increase in bicarbonate
by 2.8mmol/l. As this claim is based on a simple associative
relationship,4 it provides no support for a cause-and-effect
relationship of albumin to plasma bicarbonate.
Finally, the lack of deﬁnition of the secondary ventilatory
response to metabolic acid–base disorders is indeed one of the
limitations of the physicochemical approach, but certainly not
its most serious drawback, as Dr Berend asserts.
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Acute kidney injury and long-term
outcomes: more to learn
To the Editor: In a retrospective case–control study, Lo et al.1
concluded that hemodialysis-requiring acute renal failure
(HD-ARF) was associated with an increased risk of
end-stage renal disease (ESRD) and all-cause mortality. This
ﬁnding is in concordance with recent studies demonstrating
an association between HD-ARF and progression to ESRD,
as well as the increased long-term mortality risk associated
with all severity stages of acute kidney injury (AKI).2–4
Although the authors used changes in serum creatinine
(sCr) for classiﬁcation of HD-ARF, it is not clear whether
the same methodology was used for selection of the
control group, assuring that patients with less severe AKI
were not misclassiﬁed, leading to potential underestimation
of risk.
In a study of 10,518 patients who were discharged after
major surgery, in which AKI was deﬁned using changes in
sCr, AKI patients not requiring dialysis comprised 485% of
the AKI cohort and had signiﬁcantly higher rates of mortality
compared with patients with no AKI.2 Even for patients with
complete renal recovery at the time of discharge, the mortality
risk was higher compared with patients without an episode of
AKI.2 Hence, less severe stages of AKI may have a more
profound effect on post-discharge morbidity and mortality
than previously appreciated, and the risk of progressive
chronic kidney disease among these patients has been
inadequately studied. We agree with the authors that in
contemporary practice only a minority of AKI patients are
subjected to any kind of follow-up regarding the progression
of kidney disease. Future studies determining the optimal
post-discharge monitoring and care of AKI patients are
warranted.
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The Authors Reply: We thank Dr Bihorac and colleagues
very much for their letter1 and interest in our recent matched
cohort study.2 We included all patients who did not suffer
dialysis-requiring acute renal failure in the control group. We
believe that had we removed from the control group those
with non-dialysis requiring acute renal failure, our observed
large effect size would be even greater. We agree that more
research should be conducted regarding the long-term sequelae
of non-dialysis requiring acute renal failure. This is one of
the key goals of the ongoing Assessment, Serial Evaluation,
and Subsequent Sequelae in AKI longitudinal cohort study
sponsored by the National Institutes of Health (http://grants.
nih.gov/grants/guide/rfa-ﬁles/RFA-DK-07-009.html).
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